News

Sunnyvale, California, September 18, 2013 - Molecular Devices® today announced the launch of the EarlyTox™ Cardiotoxicity Kit, a fast, simple and reliable fluorescence-based kit for identifying cardiotoxicity of drug candidates early in the discovery… Read More
PORT WASHINGTON, N.Y., September 16, 2013 — ForteBio, a division of Pall Life Sciences and a leading supplier of instrumentation for accelerated drug discovery and development, today announced the launch of the Octet® HTX system, the new flagship member… Read More
New reagent kit combines Fura-2 dye with Molecular Devices' masking technology to offer improved ease of use and data quality Sunnyvale, California, August 19, 2013 - Molecular Devices® today announced the launch of its Fura-2 QBTTM Calcium Kit. This new… Read More
Enhanced system enables the widest assay windows to allow kinetic studies of drug binding for use-dependent compounds Sunnyvale, California, July 17, 2013 - Molecular Devices®, market leader in the electrophysiology and biophysical research markets for… Read More
Sunnyvale, California, May 28, 2013 - Molecular Devices®, market leader in the electrophysiology and biophysical research markets for over 30 years, announced today it has made an agreement with Fluxion Biosciences to become global distributor for the… Read More
Sunnyvale, California, May 9 2013 - Molecular Devices, market leader in the electrophysiology and biophysical research markets for over 30 years, announced today the launch of its next generation AxonTM Digidata® 1550 Low-Noise Data Acquisition System.… Read More
Sunnyvale, California, April 23 2013 - Molecular Devices announced today the launch of FLIPR® Calcium 6 Assay Kits, the latest addition to their extensive range of calcium assay kits to address diversified GPCR and ion channel targets. Featuring a… Read More
Sunnyvale, CA, February 13, 2013 - Molecular Devices®, market leader in microplate reader technology for over 25 years, has announced today the launch of its SpectraMax® i3 Multi-Mode Detection Platform. The system is available as a stand-alone reader… Read More
PORT WASHINGTON, N.Y., February 12, 2013 — ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its new… Read More
The SpectraMax® M5e Microplate Reader's unique mechanics allows efficient adaptation to the zero gravity in space and offers the most advanced features in one unit, making it the ideal candidate for handling research applications in a rigorous… Read More